Nifty

:

22570.35

Sensex

:

74339.44

167.95 (0.75%)
486.50 (0.66%)

Login

Nifty
Sensex

:
:

22570.35
74339.44

167.95 (0.75%)
486.50 (0.66%)

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

36/99

BSE: 524669 | NSE: HESTERBIO

Watchlist

NSE BSE

1660.70

25-Apr-2024

Open
High
Low
Previous Close

1659.25
1680.65
1649.00
1684.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11634
193.12
1939.95
1292.85

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,410.99
77.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,663.81
0.48%
5.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.44
8.36
7.48

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.50
-5.83
-6.00

PAT CAGR (%)

10 Years
5 Years
3 Years

10.92
-8.52
-8.21

P:E (Median)

8 Years
5 Years
3 Years

47.47
50.71
51.77

P:BV (Average)

8 Years
5 Years
3 Years

7.09
6.79
6.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

24.02
24.39
26.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 65.50 70.77 -7.45% 66.43 72.00 -7.74% 80.34 50.53 58.99% 60.70 50.25 20.80%
Expenses 53.94 51.79 4.15% 54.44 56.22 -3.17% 68.98 41.33 66.90% 49.78 40.20 23.83%
EBITDA 11.57 18.99 -39.07% 11.99 15.78 -24.02% 11.37 9.20 23.59% 10.92 10.05 8.66%
EBIDTM 17.66% 26.83% 18.05% -141.38% 14.15% 18.20% 17.99% 20.01%
Other Income 0.98 0.96 2.08% 1.22 2.18 -44.04% 0.86 1.23 -30.08% 0.95 1.08 -12.04%
Interest 1.37 3.14 -56.37% 1.48 1.74 -14.94% 0.94 1.27 -25.98% 0.35 1.38 -74.64%
Depreciation 2.57 2.44 5.33% 2.58 2.34 10.26% 2.55 2.39 6.69% 2.62 2.55 2.75%
PBT 8.61 14.38 -40.13% 9.16 13.88 -34.01% 8.73 6.77 28.95% 8.90 7.20 23.61%
Tax 2.14 3.65 -41.37% 2.38 3.53 -32.58% 2.26 1.76 28.41% 2.64 2.26 16.81%
PAT 6.47 10.73 -39.70% 6.78 10.35 -34.49% 6.47 5.00 29.40% 6.26 4.95 26.46%
PATM 9.88% 15.16% 10.21% 56.25% 8.05% 9.91% 10.32% 9.85%
EPS 7.62 12.62 -39.62% 7.98 12.17 -34.43% 7.61 5.89 29.20% 7.37 5.82 26.63%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 66.98 74.94 -10.62% 70.45 73.15 -3.69% 87.85 50.70 73.27% 67.30 56.47 19.18%
Expenses 56.83 56.19 1.14% 57.24 60.41 -5.25% 73.49 43.27 69.84% 55.62 46.14 20.55%
EBITDA 10.16 18.76 -45.84% 13.22 12.74 3.77% 14.36 7.43 93.27% 11.68 10.33 13.07%
EBIDTM 15.16% 25.03% 18.76% -4.88% 16.35% 14.66% 17.35% 18.28%
Other Income 0.99 4.39 -77.45% 4.36 4.45 -2.02% 1.15 3.12 -63.14% 3.19 7.19 -55.63%
Interest 2.19 3.89 -43.70% 8.07 2.46 228.05% 2.57 1.60 60.62% 1.37 1.50 -8.67%
Depreciation 3.75 5.24 -28.44% 4.28 5.03 -14.91% 5.40 5.06 6.72% 5.37 5.13 4.68%
PBT 5.20 14.02 -62.91% 5.21 9.71 -46.34% 7.54 3.89 93.83% 8.12 10.89 -25.44%
Tax 2.39 3.84 -37.76% 2.72 3.67 -25.89% 2.20 1.90 15.79% 2.71 2.30 17.83%
PAT 2.81 10.18 -72.40% 2.49 6.04 -58.77% 5.34 1.99 168.34% 5.42 8.58 -36.83%
PATM 4.20% 13.58% 3.54% -10.84% 6.08% 3.92% 8.05% 15.20%
EPS 4.68 13.15 -64.41% 4.80 -0.96 - 6.90 4.66 48.07% 5.33 9.08 -41.30%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 272.97 254.00 219.35 208.48 169.43 171.19 134.79 123.28 100.89 90.04 69.05 Net Sales Growth 12.08% 15.80% 5.21% 23.05% -1.03% 27.00% 9.34% 22.19% 12.05% 30.40% Cost Of Goods Sold 96.41 79.88 63.84 53.39 29.24 29.21 23.31 29.89 19.75 25.29 11.39 Gross Profit 176.56 174.12 155.51 155.08 140.19 141.97 111.47 93.39 81.14 64.75 57.65 GP Margin 64.68% 68.55% 70.90% 74.39% 82.74% 82.93% 82.70% 75.75% 80.42% 71.91% 83.49% Total Expenditure 227.14 199.32 158.78 136.48 116.70 103.42 85.19 82.21 67.50 63.87 43.72 Power & Fuel Cost - 9.95 8.74 6.93 7.29 7.08 5.84 5.31 5.81 4.70 4.40 % Of Sales - 3.92% 3.98% 3.32% 4.30% 4.14% 4.33% 4.31% 5.76% 5.22% 6.37% Employee Cost - 47.92 39.12 33.45 37.16 26.74 22.29 18.32 15.44 12.24 9.84 % Of Sales - 18.87% 17.83% 16.04% 21.93% 15.62% 16.54% 14.86% 15.30% 13.59% 14.25% Manufacturing Exp. - 10.54 10.17 10.79 11.31 10.95 9.24 6.97 7.85 4.94 5.28 % Of Sales - 4.15% 4.64% 5.18% 6.68% 6.40% 6.86% 5.65% 7.78% 5.49% 7.65% General & Admin Exp. - 21.60 14.50 13.24 16.34 11.77 12.92 11.35 10.23 8.65 7.22 % Of Sales - 8.50% 6.61% 6.35% 9.64% 6.88% 9.59% 9.21% 10.14% 9.61% 10.46% Selling & Distn. Exp. - 24.68 17.16 13.68 11.42 16.02 9.09 8.15 6.77 7.14 4.87 % Of Sales - 9.72% 7.82% 6.56% 6.74% 9.36% 6.74% 6.61% 6.71% 7.93% 7.05% Miscellaneous Exp. - 4.76 5.26 5.00 3.95 1.65 2.50 2.22 1.64 0.90 4.87 % Of Sales - 1.87% 2.40% 2.40% 2.33% 0.96% 1.85% 1.80% 1.63% 1.00% 1.03% EBITDA 45.85 54.68 60.57 72.00 52.73 67.77 49.60 41.07 33.39 26.17 25.33 EBITDA Margin 16.80% 21.53% 27.61% 34.54% 31.12% 39.59% 36.80% 33.31% 33.10% 29.06% 36.68% Other Income 4.01 5.53 4.66 1.65 2.93 3.10 1.88 0.73 0.87 0.33 0.77 Interest 4.14 6.50 2.47 3.95 5.03 3.54 2.32 3.21 3.69 4.41 6.43 Depreciation 10.32 9.79 9.50 9.63 9.38 7.57 5.45 5.51 5.73 5.29 5.38 PBT 35.40 43.92 53.26 60.06 41.23 59.75 43.71 33.09 24.85 16.80 14.29 Tax 9.42 11.58 13.74 14.88 10.01 15.90 13.15 8.15 5.63 4.87 4.20 Tax Rate 26.61% 26.37% 25.80% 27.16% 24.28% 26.61% 30.08% 24.63% 22.66% 25.04% 29.39% PAT 25.98 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 14.58 10.09 PAT before Minority Interest 25.98 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 14.58 10.09 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.52% 12.73% 18.02% 19.14% 18.43% 25.61% 22.67% 20.23% 19.05% 16.19% 14.61% PAT Growth -16.27% -18.17% -0.95% 27.80% -28.80% 43.49% 22.53% 29.76% 31.82% 44.50% EPS 30.56 38.05 46.49 46.94 36.73 51.59 35.95 29.34 22.61 17.15 11.87

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 292.58 266.09 235.01 214.33 183.27 178.07 135.94 123.11 100.89 90.64 69.05 Net Sales Growth 14.62% 13.22% 9.65% 16.95% 2.92% 30.99% 10.42% 22.02% 11.31% 31.27% Cost Of Goods Sold 94.66 77.49 64.85 50.23 27.98 28.47 23.31 28.45 19.75 25.32 11.39 Gross Profit 197.92 188.60 170.15 164.11 155.29 149.60 112.63 94.65 81.14 65.32 57.65 GP Margin 67.65% 70.88% 72.40% 76.57% 84.73% 84.01% 82.85% 76.88% 80.42% 72.07% 83.49% Total Expenditure 243.18 215.69 175.02 145.67 127.87 110.03 88.68 82.09 67.50 65.90 44.60 Power & Fuel Cost - 12.74 10.28 7.57 8.13 7.83 6.37 5.59 5.81 4.77 4.40 % Of Sales - 4.79% 4.37% 3.53% 4.44% 4.40% 4.69% 4.54% 5.76% 5.26% 6.37% Employee Cost - 56.02 45.33 38.92 40.65 28.93 23.24 18.32 15.44 12.32 9.84 % Of Sales - 21.05% 19.29% 18.16% 22.18% 16.25% 17.10% 14.88% 15.30% 13.59% 14.25% Manufacturing Exp. - 12.67 11.51 11.60 11.98 11.34 9.45 7.06 7.85 5.25 5.28 % Of Sales - 4.76% 4.90% 5.41% 6.54% 6.37% 6.95% 5.73% 7.78% 5.79% 7.65% General & Admin Exp. - 24.89 19.20 15.29 13.47 13.72 13.81 11.47 10.23 8.90 7.23 % Of Sales - 9.35% 8.17% 7.13% 7.35% 7.70% 10.16% 9.32% 10.14% 9.82% 10.47% Selling & Distn. Exp. - 26.34 17.31 14.73 18.97 16.77 9.11 8.15 6.77 7.14 4.87 % Of Sales - 9.90% 7.37% 6.87% 10.35% 9.42% 6.70% 6.62% 6.71% 7.88% 7.05% Miscellaneous Exp. - 5.54 6.53 7.34 6.69 2.98 3.40 3.05 1.64 2.20 4.87 % Of Sales - 2.08% 2.78% 3.42% 3.65% 1.67% 2.50% 2.48% 1.63% 2.43% 2.29% EBITDA 49.42 50.40 59.99 68.66 55.40 68.04 47.26 41.02 33.39 24.74 24.45 EBITDA Margin 16.89% 18.94% 25.53% 32.03% 30.23% 38.21% 34.77% 33.32% 33.10% 27.29% 35.41% Other Income 9.69 15.36 13.74 4.68 6.37 7.21 2.55 0.42 0.88 0.34 0.79 Interest 14.20 9.32 4.06 6.60 7.37 6.63 4.04 3.50 3.72 4.83 6.46 Depreciation 18.80 20.70 16.58 13.31 13.07 11.76 9.66 7.00 5.75 5.92 5.41 PBT 26.07 35.74 53.08 53.42 41.33 56.86 36.12 30.93 24.81 14.33 13.37 Tax 10.02 12.12 14.02 15.40 10.32 16.16 13.05 8.15 5.63 4.82 4.20 Tax Rate 38.43% 33.91% 26.41% 30.74% 24.97% 28.42% 36.13% 26.35% 22.69% 28.39% 31.41% PAT 16.06 26.63 39.32 34.43 29.17 41.56 25.62 23.55 19.19 12.47 9.45 PAT before Minority Interest 14.05 28.04 39.48 34.70 31.00 40.69 23.07 22.79 19.18 12.17 9.16 Minority Interest -2.01 -1.41 -0.16 -0.27 -1.83 0.87 2.55 0.76 0.01 0.30 0.29 PAT Margin 5.49% 10.01% 16.73% 16.06% 15.92% 23.34% 18.85% 19.13% 19.02% 13.76% 13.69% PAT Growth -40.05% -32.27% 14.20% 18.03% -29.81% 62.22% 8.79% 22.72% 53.89% 31.96% EPS 18.89 31.33 46.26 40.51 34.32 48.89 30.14 27.71 22.58 14.67 11.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 292.38 268.43 237.58 203.08 179.44 146.08 122.09 100.32 84.25 75.97 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 283.88 259.93 229.07 194.57 170.93 137.57 113.58 91.81 75.74 67.47 Non-Current Liabilities 116.96 81.17 9.79 15.89 21.51 21.98 22.36 21.05 21.29 11.13 Secured Loans 83.40 73.25 2.68 7.45 11.37 14.61 18.66 12.87 14.52 5.44 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.90 0.76 Long Term Provisions 1.72 1.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 136.47 74.84 34.65 58.22 39.30 42.43 33.99 37.45 34.87 41.71 Trade Payables 28.71 11.03 14.03 13.61 8.05 7.85 7.47 5.84 4.63 4.46 Other Current Liabilities 46.59 29.34 15.11 12.37 10.05 9.33 7.82 8.55 6.22 7.19 Short Term Borrowings 57.34 33.29 1.71 31.80 20.94 24.19 17.51 21.04 20.08 26.25 Short Term Provisions 3.83 1.18 3.81 0.44 0.26 1.06 1.18 2.02 3.95 3.80 Total Liabilities 545.81 424.44 282.02 277.19 240.25 210.49 178.44 158.82 140.41 128.81 Net Block 108.22 84.31 86.69 96.76 100.81 66.74 60.85 61.57 56.53 50.68 Gross Block 199.00 171.17 164.64 166.61 161.97 120.89 109.55 105.07 94.40 83.48 Accumulated Depreciation 90.78 86.86 77.95 69.85 61.02 54.15 48.70 43.50 37.87 32.81 Non Current Assets 329.77 257.97 142.41 154.01 140.84 121.36 103.63 91.64 87.65 75.52 Capital Work in Progress 148.61 81.91 3.72 0.87 0.42 30.47 21.29 10.47 14.27 13.15 Non Current Investment 64.69 64.69 43.88 40.67 28.22 14.48 8.60 8.67 8.88 3.63 Long Term Loans & Adv. 6.83 24.20 5.32 11.83 9.81 9.59 12.41 10.93 7.97 8.06 Other Non Current Assets 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 0.00 0.00 Current Assets 216.05 166.47 139.61 123.18 99.40 89.13 74.81 67.18 52.77 53.30 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 79.22 70.73 57.01 60.43 48.50 38.70 33.07 33.62 29.11 35.59 Sundry Debtors 82.36 56.92 45.55 44.76 32.67 31.94 26.71 26.24 17.76 14.06 Cash & Bank 5.96 1.98 1.24 5.19 2.49 11.95 11.48 5.26 4.38 1.06 Other Current Assets 48.51 2.83 6.30 0.96 15.74 6.54 3.56 2.07 1.51 2.59 Short Term Loans & Adv. 43.06 34.01 29.50 11.84 12.95 5.69 3.30 2.07 1.51 2.59 Net Current Assets 79.58 91.64 104.96 64.96 60.10 46.70 40.82 29.73 17.89 11.59 Total Assets 545.82 424.44 282.02 277.19 240.24 210.49 178.44 158.82 140.42 128.82

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 279.73 259.99 228.31 201.07 177.46 140.63 121.95 101.71 84.92 75.01 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 271.22 251.48 219.80 192.56 168.95 132.13 113.44 93.20 76.41 66.50 Non-Current Liabilities 232.72 197.87 113.72 96.64 69.64 44.41 48.32 41.28 37.66 20.46 Secured Loans 184.85 164.54 82.84 76.48 58.35 36.54 44.62 33.09 30.89 14.76 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.90 0.76 Long Term Provisions 1.93 1.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 148.70 96.90 61.37 83.46 48.66 54.63 38.01 38.20 35.01 45.47 Trade Payables 29.98 18.02 28.09 20.02 8.75 7.90 7.47 5.84 4.63 4.52 Other Current Liabilities 55.96 42.81 22.52 30.44 17.15 20.26 11.04 9.30 6.35 7.41 Short Term Borrowings 58.86 34.84 3.28 32.54 22.50 25.41 18.32 21.04 20.08 29.74 Short Term Provisions 3.90 1.22 7.48 0.46 0.26 1.07 1.18 2.02 3.95 3.80 Total Liabilities 669.97 562.17 411.05 386.59 299.46 244.04 212.88 185.84 160.46 142.22 Net Block 259.37 237.17 132.76 142.54 144.82 110.22 102.62 64.63 59.60 53.82 Gross Block 385.80 348.16 228.12 226.04 215.94 170.22 152.95 108.25 97.57 86.69 Accumulated Depreciation 126.43 110.99 95.36 83.50 70.98 60.00 50.33 43.62 37.97 32.87 Non Current Assets 442.37 367.40 249.54 227.29 157.80 145.59 132.91 111.63 100.45 85.12 Capital Work in Progress 148.61 81.91 109.17 74.15 7.05 31.81 21.29 36.46 32.60 20.55 Non Current Investment 25.30 21.24 0.00 0.00 0.00 0.00 0.00 0.07 0.28 0.28 Long Term Loans & Adv. 7.67 24.22 4.82 6.74 4.34 3.48 8.52 10.47 7.97 10.47 Other Non Current Assets 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 0.00 0.00 Current Assets 227.59 194.76 161.50 159.31 141.66 98.45 79.97 74.20 60.00 57.10 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 84.81 75.38 62.22 63.97 50.79 39.76 33.41 33.62 29.11 35.59 Sundry Debtors 79.63 55.28 49.21 58.44 32.87 32.29 26.53 26.24 17.76 14.06 Cash & Bank 14.82 25.20 21.27 23.53 41.05 13.39 11.48 5.28 6.58 4.85 Other Current Assets 48.33 5.20 2.56 5.18 16.95 13.01 8.54 9.05 6.55 2.60 Short Term Loans & Adv. 42.31 33.70 26.24 8.19 11.32 8.95 5.06 2.49 6.55 2.60 Net Current Assets 78.90 97.87 100.14 75.84 92.99 43.82 41.95 36.00 25.00 11.63 Total Assets 669.96 562.16 411.04 386.60 299.46 244.04 212.88 185.83 160.45 142.22

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 33.36 15.90 41.10 25.82 36.19 32.28 27.55 18.64 20.37 11.39 PBT 43.92 53.26 54.78 41.23 59.75 43.71 33.09 24.85 18.81 14.29 Adjustment 14.55 11.70 19.61 12.25 8.50 7.34 8.74 9.31 7.23 11.60 Changes in Working Capital -17.05 -32.61 -19.80 -16.31 -16.47 -9.37 -7.22 -9.54 -0.23 -4.63 Cash after chg. in Working capital 41.43 32.34 54.59 37.17 51.78 41.67 34.61 24.62 25.82 21.26 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.06 -16.44 -13.49 -11.35 -15.58 -9.39 -7.06 -5.97 -5.45 -9.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -71.96 -110.58 -3.72 -21.33 -24.70 -26.32 -15.49 -5.68 -12.02 -14.00 Net Fixed Assets -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 -12.04 -10.39 Net Investments 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 -5.25 -0.85 Others 22.57 -5.05 0.37 -3.79 0.07 0.08 -0.26 0.98 5.27 -2.76 Cash from Financing Activity 41.38 94.96 -41.33 -1.39 -20.29 -6.24 -5.60 -11.92 -5.21 2.54 Net Cash Inflow / Outflow 2.77 0.28 -3.95 3.10 -8.80 -0.28 6.46 1.04 3.13 -0.06 Opening Cash & Equivalents 1.53 1.24 5.19 2.09 10.89 11.17 4.71 3.92 0.69 0.75 Closing Cash & Equivalent 4.30 1.53 1.24 5.19 2.09 10.89 11.17 4.96 3.92 0.69

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 23.60 8.71 58.05 36.77 46.71 38.02 34.80 18.85 19.76 9.39 PBT 40.15 53.50 50.10 41.33 56.86 36.12 30.93 24.81 18.20 13.37 Adjustment 12.39 11.10 20.34 20.13 17.92 13.63 10.86 9.38 7.34 11.91 Changes in Working Capital -20.84 -38.78 1.54 -13.75 -12.26 -2.31 0.11 -9.37 -0.33 -6.02 Cash after chg. in Working capital 31.70 25.82 71.99 47.71 62.52 47.44 41.90 24.82 25.21 19.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.11 -17.11 -13.94 -10.94 -15.81 -9.41 -7.06 -5.97 -5.45 -9.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 0.00 Cash From Investing Activity -77.00 -116.59 -38.37 -74.47 -21.73 -25.83 -30.19 -13.30 -21.21 -14.59 Net Fixed Assets -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 -12.04 -10.39 Net Investments 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 -5.25 -0.85 Others 17.53 -11.06 -34.28 -56.93 3.04 0.57 -14.96 -6.64 -3.92 -3.35 Cash from Financing Activity 41.76 111.54 -18.22 18.74 2.65 -11.08 1.83 -6.68 6.76 7.38 Net Cash Inflow / Outflow -11.64 3.66 1.46 -18.96 27.63 1.12 6.45 -1.14 5.31 2.19 Opening Cash & Equivalents 24.75 21.27 23.53 40.65 12.33 11.18 4.73 6.12 0.82 2.29 Closing Cash & Equivalent 13.16 24.75 21.27 23.53 40.65 12.33 11.18 4.99 6.12 4.48

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 343.70 315.54 279.28 238.72 210.93 171.72 143.52 117.93 101.13 89.31 ROA 6.67% 11.19% 14.27% 12.07% 19.46% 15.71% 14.79% 12.85% 10.82% 8.29% ROE 11.53% 15.62% 18.11% 16.33% 26.94% 22.79% 22.43% 20.83% 18.00% 14.03% ROCE 11.91% 17.31% 23.28% 19.74% 31.15% 26.28% 24.16% 21.79% 20.29% 20.38% Fixed Asset Turnover 1.38 1.32 1.26 1.03 1.21 1.17 1.17 1.03 1.06 0.97 Receivable days 99.32 84.52 79.06 83.41 68.88 79.13 76.95 77.96 63.99 75.19 Inventory Days 106.93 105.37 102.81 117.33 92.96 96.84 96.91 111.14 127.96 172.29 Payable days 90.79 71.61 94.44 36.28 28.05 36.46 33.72 29.57 27.98 45.03 Cash Conversion Cycle 115.46 118.28 87.43 164.47 133.79 139.51 140.15 159.53 163.98 202.45 Total Debt/Equity 0.56 0.45 0.07 0.24 0.21 0.29 0.32 0.39 0.44 0.47 Interest Cover 7.76 22.58 14.88 9.19 17.87 19.88 11.31 7.74 5.41 3.22

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 328.82 305.61 268.38 236.36 208.61 165.32 143.35 119.56 96.86 88.18 ROA 4.55% 8.11% 8.70% 9.04% 14.97% 10.10% 11.43% 11.08% 8.06% 6.89% ROE 10.39% 16.17% 16.16% 16.38% 25.59% 17.57% 20.38% 20.56% 15.46% 12.88% ROCE 9.60% 14.12% 17.33% 16.53% 26.64% 20.20% 19.75% 18.98% 16.53% 17.78% Fixed Asset Turnover 0.73 0.82 0.95 0.83 0.92 0.84 0.96 1.00 1.01 0.93 Receivable days 91.87 80.50 91.49 90.92 66.77 78.70 76.80 77.96 63.83 75.19 Inventory Days 109.08 106.00 107.25 114.27 92.80 97.89 97.55 111.14 127.14 172.29 Payable days 113.04 129.73 174.82 42.10 27.25 33.70 33.48 29.56 28.17 45.39 Cash Conversion Cycle 87.91 56.77 23.92 163.09 132.33 142.89 140.87 159.54 162.80 202.09 Total Debt/Equity 0.96 0.86 0.46 0.60 0.51 0.49 0.54 0.58 0.71 0.64 Interest Cover 5.31 14.16 8.59 6.61 9.57 9.95 9.84 7.67 4.52 3.07

Top Investors:

kuntal hasmukhlal shah

darshna dinesh kapadia

jagrut prataprai gandhi

manish prataprai gandhi

investor education and protection fund (iepf)

Annual Reports:

News Update:

Hester Biosciences - Quarterly Results
2nd Feb 2024, 12:24 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback